BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22796835)

  • 1. Counterpoint: should thoracoscopic talc pleurodesis be the first choice management for malignant pleural effusion? No.
    Light RW
    Chest; 2012 Jul; 142(1):17-19. PubMed ID: 22796835
    [No Abstract]   [Full Text] [Related]  

  • 2. Point: Should thoracoscopic talc pleurodesis be the first choice management for malignant effusion? Yes.
    Lee P
    Chest; 2012 Jul; 142(1):15-17. PubMed ID: 22796834
    [No Abstract]   [Full Text] [Related]  

  • 3. [Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases].
    Zhang W; Wang GF; Zhang H; Mu XD; Jin Z
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):600-2. PubMed ID: 19088831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The thoracoscopic talc pleurodesis with intraoperative pleural biopsy - a retrospective analysis in patients with malignant pleural effusion].
    Hoksch B; Seidel N; Beshay M; Schmid RA
    Zentralbl Chir; 2010 Feb; 135(1):54-8. PubMed ID: 20029741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of recurrent malignant pleural effusions: an ever-recurring issue?
    Maldonado F; Astoul P
    Chest; 2012 Dec; 142(6):1696. PubMed ID: 23208361
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
    Kolschmann S; Ballin A; Gillissen A
    Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
    Stefani A; Natali P; Casali C; Morandi U
    Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of medical thoracoscopy and thoracoscopic talc poudrage in patients with exudative pleural effusion.
    Verma A; Taha A; Venkateswaran S; Tee A
    Singapore Med J; 2015 May; 56(5):268-73. PubMed ID: 26034319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Talc pleurodesis for treating malignant pleural effusions.
    Rodriguez-Panadero F
    Chest; 1995 Oct; 108(4):1178-9. PubMed ID: 7555141
    [No Abstract]   [Full Text] [Related]  

  • 10. TLR2 in pleural fluid is modulated by talc particles during pleurodesis.
    Jankovicova K; Kondelkova K; Habal P; Andrys C; Krejsek J; Mandak J
    Clin Dev Immunol; 2012; 2012():158287. PubMed ID: 23304186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results.
    Basso SM; Mazza F; Marzano B; Santeufemia DA; Chiara GB; Lumachi F
    Anticancer Res; 2012 Nov; 32(11):5131-4. PubMed ID: 23155293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the efficacy of thoracoscopy and talc poudrage versus pleurodesis using talc slurry (TAPPS trial): protocol of an open-label randomised controlled trial.
    Bhatnagar R; Laskawiec-Szkonter M; Piotrowska HE; Kahan BC; Hooper CE; Davies HE; Harvey JE; Miller RF; Rahman NM; Maskell NA
    BMJ Open; 2014 Nov; 4(11):e007045. PubMed ID: 25428632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion.
    Yim AP; Chan AT; Lee TW; Wan IY; Ho JK
    Ann Thorac Surg; 1996 Dec; 62(6):1655-8. PubMed ID: 8957368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleurodesis.
    Lamb C; Li A; Thakkar D; Lee P
    Semin Respir Crit Care Med; 2019 Jun; 40(3):375-385. PubMed ID: 31525812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of systemic and local inflammation parameters in talc pleurodesis assessment.
    Habal P; Omran N; Jankovicova K; Krejsek J; Mandak J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):234-41. PubMed ID: 25059234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoracoscopic talc poudrage for malignant effusions: should it be the procedure of choice?
    Yim AP; Izzat MB
    Chest; 1997 Oct; 112(4):1148. PubMed ID: 9377939
    [No Abstract]   [Full Text] [Related]  

  • 17. Success rate of medical thoracoscopy and talc pleurodesis in malignant pleurisy: A single-centre experience.
    Leemans J; Dooms C; Ninane V; Yserbyt J
    Respirology; 2018 Jun; 23(6):613-617. PubMed ID: 29320805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review.
    Tan C; Sedrakyan A; Browne J; Swift S; Treasure T
    Eur J Cardiothorac Surg; 2006 May; 29(5):829-38. PubMed ID: 16626967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleurodesis for malignant pleural effusions: current controversies and variations in practices.
    West SD; Davies RJ; Lee YC
    Curr Opin Pulm Med; 2004 Jul; 10(4):305-10. PubMed ID: 15220757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Talc slurry versus talc insufflation revisited.
    Yim AP; Izzat MB
    Ann Thorac Surg; 1997 Jul; 64(1):285. PubMed ID: 9236390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.